FIORETTO, BIANCA SAVERIA
 Distribuzione geografica
Continente #
EU - Europa 655
NA - Nord America 606
AS - Asia 242
AF - Africa 3
OC - Oceania 3
SA - Sud America 1
Totale 1.510
Nazione #
US - Stati Uniti d'America 602
RU - Federazione Russa 363
IT - Italia 126
SG - Singapore 91
HK - Hong Kong 62
IE - Irlanda 60
CN - Cina 54
SE - Svezia 35
IN - India 21
FI - Finlandia 17
DE - Germania 16
GB - Regno Unito 10
JO - Giordania 8
BE - Belgio 5
CH - Svizzera 5
CA - Canada 4
LU - Lussemburgo 4
UA - Ucraina 4
AU - Australia 3
ES - Italia 3
JP - Giappone 3
KR - Corea 3
NL - Olanda 3
AT - Austria 2
CI - Costa d'Avorio 2
BR - Brasile 1
DK - Danimarca 1
RO - Romania 1
TN - Tunisia 1
Totale 1.510
Città #
Santa Clara 297
Singapore 81
Chandler 58
Dublin 56
Hong Kong 46
Florence 37
Ashburn 35
Shanghai 20
Fiesole 17
Milan 14
Helsinki 12
Mumbai 11
Munich 11
West Jordan 10
Beijing 9
Kent 8
Fairfield 7
Sesto Fiorentino 7
Moscow 6
Houston 5
Lappeenranta 5
Romola 5
Hillsboro 4
Kochi 4
Seattle 4
Bern 3
Boston 3
London 3
Louvain-la-Neuve 3
Medford 3
Perth 3
Princeton 3
Pune 3
Rome 3
Shenzhen 3
Toronto 3
Washington 3
Wilmington 3
Woodbridge 3
Yubileyny 3
Abidjan 2
Arezzo 2
Camerino 2
Catania 2
Forest City 2
Gazzo 2
Genoa 2
Ghent 2
Hangzhou 2
Llagostera 2
Manchester 2
Matsuyama 2
Monmouth 2
New Market 2
New York 2
North Bergen 2
Padova 2
Prato 2
Scarperia e San Piero 2
Sparks 2
St Petersburg 2
Sunderland 2
Thrissur 2
Tianjin 2
Wallisellen 2
Yongin-si 2
Ancona 1
Andover 1
Ann Arbor 1
Baoding 1
Bergamo 1
Copenhagen 1
Fara Gera d'Adda 1
Groningen 1
Hamm 1
Iasi 1
Jacksonville 1
Massarosa 1
Nanjing 1
Nuremberg 1
Rui'an 1
San Diego 1
Schermbeck 1
Seoul 1
São Paulo 1
Taiyuan 1
Tokyo 1
Vienna 1
Vimodrone 1
Yekaterinburg 1
Totale 890
Nome #
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 104
STIMULATION OF SOLUBLE GUANYLATE CYCLASE (sGC) FOSTERS ANGIOGENESIS AND BLUNTS ENDOTHELIAL-TO-MESENCHYMAL TRANSITION (EndoMT) OF SYSTEMIC SCLEROSIS (SSc) DERMAL MICROVASCULAR ENDOTHELIAL CELLS 85
The Role of Pro-fibrotic Myofibroblasts in Systemic Sclerosis: From Origin to Therapeutic Targeting 77
Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis 70
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 68
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis 67
The Soluble Guanylate Cyclase Stimulator BAY 41-2272 Attenuates Transforming Growth Factor β1-Induced Myofibroblast Differentiation of Human Corneal Keratocytes 66
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 66
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 64
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 64
The contribution of endothelial cells to tissue fibrosis 62
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells 59
Immunohistochemical and ultrastructural identification of telocytes in the lamina propria of human vaginal mucosa 57
Skin telocyte secretome as conditioned medium prevents profibrotic differentiation of skin fibroblasts into myofibroblasts 56
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of scleroderma endothelial cells 55
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 53
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 50
Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment 48
Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review 48
Blockade of Sialylation with Decrease in Polysialic Acid Levels Counteracts Transforming Growth Factor β1-Induced Skin Fibroblast-to-Myofibroblast Transition 47
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 46
Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis 45
Pharmacological Stimulation of Soluble Guanylate Cyclase Counteracts the Profibrotic Activation of Human Conjunctival Fibroblasts 44
Recent Insights into Cellular and Molecular Mechanisms of Defective Angiogenesis in Systemic Sclerosis 40
The differential crosstalk of the skin–gut microbiome axis as a new emerging actor in systemic sclerosis 34
Blockade of sialylation with decrease in polysialic acid levels counteracts transforming growth factor β1-induced skin fibroblast-to-myofibroblast transition 32
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 30
Gut microbiota in very early systemic sclerosis: the first case-control taxonomic and functional characterisation highlighting an altered butyric acid profile 6
null 2
Totale 1.545
Categoria #
all - tutte 5.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 4 6 0 0
2021/202246 2 0 1 1 2 1 0 0 8 0 1 30
2022/2023255 16 19 12 20 13 48 38 15 33 4 10 27
2023/2024306 4 21 34 19 21 34 23 70 7 20 20 33
2024/2025928 57 153 131 225 362 0 0 0 0 0 0 0
Totale 1.545